-
-
-
-
-
-
-
Editas Medicine (EDIT) and Bristol Myers Squibb (BMY) Extend Alpha-Beta T Cell Collaboration
-
-
-
-
-
-
-
NRx Pharmaceuticals (NRXP) Reports Promising Findings in Phase 2b/3 Clinical Trial of NRX-101
-
-
-
-
-
-
-
Medison Pharma and Alnylam Pharmaceuticals (ALNY) Announce Expansion of their Multi-Regional Partnership in Europe and Israel
-
-
-
-
-
-
-
FDA Takes Action Aimed at Helping to Ensure the Safety and Effectiveness of Laboratory Developed Tests
-
-
-
-
-
-
-
SELLAS Life Sciences (SLS) Announces Positive Recommendation of Independent Data Monitoring Committee Following Completion of Enrollment in REGAL Phase 3 Study
-
-
-
-
-
-
-
Moderna (MRNA) Licenses COVID-19-related Intellectual Property to a Pharmaceutical Company in Japan
-
-
-
-
-
-
-
Ocugen (OCGN) Announces OCU400 Phase 1/2 Data Presentation
-
66,954 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.